Table 1. Description of women is study sample (n = 1548).
| Age (years) | n | % |
|---|---|---|
| Median (IQR) | 26 (23, 30) | |
| 15–20 | 145 | 9.4 |
| 21–25 | 524 | 33.9 |
| 26–30 | 501 | 32.4 |
| 31–35 | 254 | 16.4 |
| >35 | 124 | 8.0 |
| Household registration | ||
| This county | 1304 | 84.2 |
| Other county in Yunnan | 202 | 13.1 |
| Other province | 24 | 1.6 |
| Other country | 18 | 1.2 |
| Ethnicity | ||
| Han | 748 | 48.3 |
| Non-Han minority | 800 | 51.7 |
| Occupation | ||
| Peasants | 1142 | 73.9 |
| Migrant workers | 94 | 6.1 |
| Housework or unemployed | 216 | 14.0 |
| Workers/white collar/other/unknown | 96 | 6.0 |
| Marital status | ||
| Married | 1481 | 95.7 |
| Living with partner | 21 | 1.4 |
| Single | 39 | 2.5 |
| Widowed/divorced | 7 | 0.5 |
| Highest education level | ||
| No education | 187 | 12.1 |
| Primary school | 553 | 35.8 |
| Junior high | 637 | 41.2 |
| Senior high | 131 | 8.5 |
| College | 38 | 2.5 |
| Year of enrollment | ||
| 2010 | 505 | 32.6 |
| 2011 | 504 | 32.6 |
| 2012 | 539 | 34.8 |
| Husband/partner tested for HIV | ||
| Yes | 1232 | 79.6 |
| No | 236 | 15.3 |
| Unknown | 80 | 5.2 |
| Husband/partner's HIV status (n = 1232) | ||
| Positive | 530 | 43 |
| Negative | 680 | 55.2 |
| Indeterminate | 22 | 1.8 |
| Site of delivery | ||
| Municipal hospital | 294 | 19.0 |
| County hospital | 1161 | 75.0 |
| Township hospital | 80 | 5.2 |
| Home / other | 13 | 0.8 |
| Mode of delivery | ||
| Emergency cesarean section | 255 | 16.5 |
| Elective cesarean section | 428 | 27.7 |
| Vaginal birth | 865 | 55.9 |
| Number of births | ||
| 1 baby | 1534 | 99.1 |
| Twins | 14 | 0.9 |
| Maternal PMTCT regimen initiation | ||
| Pre-natal | 1241 | 80.2 |
| 1st trimester | 339 | 21.9 |
| 2nd trimester | 639 | 41.3 |
| 3rd trimester | 263 | 17.0 |
| Labor and Delivery | 246 | 15.9 |
| No ART | 61 | 3.9 |
| Maternal ARV regimen | ||
| cART during pregnancy | 1041 | 67.3 |
| scAZT | 200 | 12.9 |
| cART during L&D | 229 | 14.8 |
| sdNVP | 17 | 1.1 |
| No ARV during pregnancy or L&D | 61 | 3.9 |
Notes: PMTCT prevention of mother-to-child transmission; L&D labor and delivery; cART combination antiretroviral therapy; ARV antiretrovirals; scAZT short course zidovudine; sdNVP single-dose nevirapine.